A carregar...
Tailoring therapy for ischemic cardiomyopathy: is Laplace’s law enough?
The burden of heart failure has long plagued the productive years of the population, with therapeutic advances in the timely treatment of ischemic heart disease decreasing its associated mortality. Angiotensin-converting enzyme inhibitors and β-blockers have impacted heart failure therapeutics in a...
Na minha lista:
| Publicado no: | Ther Adv Cardiovasc Dis |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5933553/ https://ncbi.nlm.nih.gov/pubmed/28689451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753944717718719 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|